LEISEGANG VIDEO COLPOSCOPE

K981958 · Netoptix Corp. · HEX · Oct 19, 1998 · Obstetrics/Gynecology

Device Facts

Record IDK981958
Device NameLEISEGANG VIDEO COLPOSCOPE
ApplicantNetoptix Corp.
Product CodeHEX · Obstetrics/Gynecology
Decision DateOct 19, 1998
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 884.1630
Device ClassClass 2

Intended Use

The Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor.

Device Story

Leisegang Video Colposcope provides magnified visualization of vaginal, cervical, and external genital tissues. Device consists of CCD camera, halogen light source, and green filter mounted on mobile base. Unlike traditional binocular colposcopes, this system displays images exclusively on a color monitor. Operated by clinicians in clinical settings to identify abnormalities and guide biopsy procedures. Integrated imaging system allows physicians to record and review tissue images over time. External VCR or video printer may be connected to produce hard copies. Device facilitates clinical decision-making by providing high-resolution visual assessment of tissue morphology, aiding in the detection of lesions or pathological changes.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Non-patient contacting colposcope; CCD camera imaging system; halogen light source; green filter; mobile base; working distance 250-307 mm; video output for color monitor display; analog video connectivity for recording/printing.

Indications for Use

Indicated for patients requiring magnified visualization of vaginal, cervical, and external genital tissues for the diagnosis of abnormalities and selection of biopsy sites.

Regulatory Classification

Identification

A colposcope is a device designed to permit direct viewing of the tissues of the vagina and cervix by a telescopic system located outside the vagina. It is used to diagnose abnormalities and select areas for biopsy. This generic type of device may include a light source, cables, and component parts.

Special Controls

*Classification.* Class II (special controls). The device, when it is a standard colposcope (or colpomicroscope) that uses only a white light source, does not use filters other than a green filter, does not include image analysis software, and is not smartphone-based, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # 510(k) SUMMARY FOR LEISEGANG VIDEO COLPOSCOPE #### SPONSOR/APPLICANT NAME, ADDRESS, TELEPHONE NUMBER 1. Leisegang Medical, Inc. 6401 Congress Avenue Boca Raton, Florida Telephone (561) 994-0202 (561) 994-6603 Facsimile ## Contact Person: Debbie Iampietro Director of Quality Assurance ## Date of Summary Preparation: June 3, 1998 - 2. DEVICE NAME Leisegang Video Colposcope Proprietary Name: Colposcope Common/Usual Name: . . . Colposcope and Accessories Classification Name: ### 3. IDENTIFICATION OF THE PREDICATE OR LEGALLY MARKETED DEVICE(S) TO WHICH EQUIVALENCE IS BEING CLAIMED Leisegang Model 1D Colposcope, manufactured by Leisegang Medical, Inc., K940094 and the Model 88000 and 89000 Video Colposcopes, manufactured by Welch Allyn, Inc. K955635. {1}------------------------------------------------ ### DEVICE DESCRIPTION 4. The Galileo Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor. The Leisegang Video Colposcope consists of a CCD camera with a halogen light source, green filter and is mounted on a mobile base. ### 5. INTENDED USE The Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed on a color monitor. ## A STATEMENT OF HOW THE TECHNOLOGICAL CHARACTERISTICS OF THE DEVICE 6. Compare to Those of the Predicate or Legally Marketed Device(s) CITED The Galileo, Leisegang and Welch Allyn Colposcopes are all intended to permit viewing and imaging of the tissues of the vagina and cervix to diagnose abnormalities and select areas for biopsy. While the predicate Leisegang devices are video adaptable, the Welch Allyn and the proposed Galileo Leisegang devices contain integrated imaging systems. These imaging systems provide the physician with a means to record pictures of the tissues for review over time. All three devices function as non-patient contacting Colposcopes with working distances of 250 to 307 mm. The proposed Leisegang and the predicate Leisegang devices are standard Colposcopes in that the tissue is magnified and viewed directly via binocular microscopes with the option of using a video monitor. Operation of the Welch Allyn device differs in that the target image is always projected onto a video monitor rather than viewed directly through eyepieces. All three devices have imaging capabilities. The predicate Leisegang Colposcopes have a video adaptor to allow for recording of the examination procedure. The video system of the proposed Galileo Leisegang and the Welch Allyn colposcopes are integral to its operation as the tissue can only be viewed by way of the video {2}------------------------------------------------ monitor. A VCR/Video Printer can be used to produce hard copies of images obtained using both the proposed and predicate Leisegang and Welch Allyn Colposcopes. {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features an abstract eagle design, with three stylized lines forming the body and wings. The words "DEPARTMENT OF HEALTH & HUMAN..." are arranged in a circular pattern around the left side of the eagle. The letters "USA" are on the right side of the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 OCT 1 9 1998 Ms. Debbie Iampietro Director of QA/RA Galileo Corporation Galileo Park P.O. Box 550 Sturbridge, MA 01566 Re: K981958 Galileo Corporation Leisegang Video Colposcopes Dated: September 10, 1998 Received: September 11, 1998 Regulatory Class: II 21 CFR 884.1630/Procode: 85 HEX Dear Ms. Iampietro: We have reviewed your Section 510/k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510kk) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmadsmain.html". Sincerely yours. Lillian Yin, Ph.D. Director, Division of Reproductive, Abdominal. Ear. Nose and Throat and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number (if known): ≤981958 Leisegang Video Colposcope Device Name: _________________________________________________________________________________________________________________________________________________________________ Indications For Use: The Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY) Concurrence of CDRH, Office of Device Evaluation (ODE) David A. Segmen (Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices K981958 15001 510(k) Number_ | Prescription Use | V | |----------------------|---| | (Per 21 CFR 801.109) | | Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (Optional Format 1-2-96)
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...